Home Applications 217242 Application 217242
Type NDA
Sponsor ARCUTIS Application Products# Product, Drug, Ingredient table Product Drug Ingredient Form Strength Reference drug Reference standard 001 ZORYVE ROFLUMILAST FOAM;TOPICAL 0.3% Yes Yes
Source provenance: Browse the complete Orange Book source catalog · source snapshot 42 .
Orange Book products# Current product rows page 1 of 1 · 1 matching rows.
Application-product, Trade name, Ingredient table Application-product Trade name Ingredient Strength Dosage form / route TE codes RLD / RS Approval date N217242-001 ZORYVE ROFLUMILAST 0.3% FOAM / TOPICAL RLD, RS 2023-12-15
Orange Book patents# Current patent rows page 1 of 1 · 26 matching rows.
Orange Book exclusivity# Current exclusivity rows page 1 of 1 · 2 matching rows.
Application-product, Exclusivity code, Expiration table Application-product Exclusivity code Expiration N217242-001 NP 2026-12-15 N217242-001 I-969 2028-05-22
Observed Orange Book product history# Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
Captured, Edition, Application-product table Captured Edition Application-product Trade name Strength Dosage form / route Product TE source text RLD / RS Approval date Source SHA-256 2026-08-18 06:07:40 2026-07 N217242-001 ZORYVE 0.3% FOAM / TOPICAL RLD, RS 2023-12-15 caaa826d4ba7…2026-02-19 14:30 UTC 2026-02 N217242-001 ZORYVE 0.3% FOAM / TOPICAL RLD, RS 2023-12-15 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N217242-001 ZORYVE 0.3% FOAM / TOPICAL RLD, RS 2023-12-15 31067a03dcf5…2025-08-23 18:47 UTC 2025-08 N217242-001 ZORYVE 0.3% FOAM / TOPICAL RLD, RS 2023-12-15 6a471c1ec25d…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N217242-001 ZORYVE 0.3% FOAM / TOPICAL RLD, RS 2023-12-15 fd3edfee7708…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N217242-001 ZORYVE 0.3% FOAM / TOPICAL RLD, RS 2023-12-15 b8a1b40f171c…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N217242-001 ZORYVE 0.3% FOAM / TOPICAL RLD, RS 2023-12-15 03ed91905a0d…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N217242-001 ZORYVE 0.3% FOAM / TOPICAL RLD, RS 2023-12-15 2680178bc6a6…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 N217242-001 ZORYVE 0.3% FOAM / TOPICAL RLD, RS 2023-12-15 5bbf6a4d5a75…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 N217242-001 ZORYVE 0.3% FOAM / TOPICAL RLD, RS 2023-12-15 d8e5a09893c0…2024-10-29 15:01 UTC 2024-10 N217242-001 ZORYVE 0.3% FOAM / TOPICAL RLD, RS 2023-12-15 d06236e962d9…2024-08-13 05:28 UTC · 3 captures of this ZIP 2024-08 N217242-001 ZORYVE 0.3% FOAM / TOPICAL RLD, RS 2023-12-15 79d66fd596c7…2024-07-13 05:37 UTC · 2 captures of this ZIP 2024-07 N217242-001 ZORYVE 0.3% FOAM / TOPICAL RLD, RS 2023-12-15 301d65b070ca…2024-06-18 03:08 UTC · 5 captures of this ZIP 2024-06 N217242-001 ZORYVE 0.3% FOAM / TOPICAL RLD, RS 2023-12-15 1e350fbaab3a…2024-05-31 18:47 UTC 2024-05 N217242-001 ZORYVE 0.3% FOAM / TOPICAL RLD, RS 2023-12-15 8072bd15b7f6…2024-03-16 18:09 UTC · 4 captures of this ZIP 2024-03 N217242-001 ZORYVE 0.3% FOAM / TOPICAL RLD, RS 2023-12-15 6a51e52b5d6a…2024-02-18 07:12 UTC 2024-02 N217242-001 ZORYVE 0.3% FOAM / TOPICAL RLD, RS 2023-12-15 1c564ffb4f44…2026-07-26 02:55 UTC · 3 captures of this ZIP 2026-06 N217242-001 ZORYVE 0.3% FOAM / TOPICAL RLD, RS 2023-12-15 a50c72e98297…
Observed Orange Book patent history# Patent history page 1 of 7 · 272 observed states.
Captured, Edition, Application-product table Captured Edition Application-product Patent Expiration Use code Coverage / status Submission date Source SHA-256 2026-08-18 06:07:40 2026-07 N217242-001 10940142 2037-06-07 Drug product 2023-12-26 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N217242-001 11793796 2037-06-07 Drug product 2023-12-26 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N217242-001 11819496 2037-06-07 U-4203 2023-12-26 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N217242-001 11819496 2037-06-07 U-3773 2023-12-26 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N217242-001 11992480 2037-06-07 U-4203 2024-06-26 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N217242-001 11992480 2037-06-07 U-3773 2024-06-26 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N217242-001 12005051 2037-06-07 U-4203 2024-07-10 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N217242-001 12005051 2037-06-07 U-3773 2024-07-10 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N217242-001 12005052 2037-06-07 Drug product 2024-07-10 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N217242-001 12011437 2037-06-07 Drug product 2024-07-10 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N217242-001 12016848 2037-06-07 Drug product 2024-07-10 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N217242-001 12042487 2037-06-07 Drug product 2024-08-16 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N217242-001 12220409 2037-06-07 Drug product 2025-03-07 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N217242-001 12257242 2037-06-07 Drug product 2025-04-22 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N217242-001 12310956 2037-06-07 U-3773 2025-06-26 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N217242-001 12310956 2037-06-07 U-4203 2025-06-26 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N217242-001 12336983 2037-06-07 Drug product 2025-07-22 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N217242-001 12390453 2037-06-07 Drug product 2025-09-12 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N217242-001 9884050 2037-06-07 Drug product 2023-12-26 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N217242-001 9907788 2037-06-07 U-4203 2023-12-26 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N217242-001 9907788 2037-06-07 U-3773 2023-12-26 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N217242-001 11129818 2037-08-25 U-4203 2023-12-26 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N217242-001 11129818 2037-08-25 U-3773 2023-12-26 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N217242-001 11707454 2041-12-03 U-3773 2023-12-26 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N217242-001 12329751 2041-12-03 U-3773 2025-07-17 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N217242-001 12453721 2042-08-19 Drug product 2025-11-24 caaa826d4ba7…2026-02-19 14:30 UTC 2026-02 N217242-001 10940142 2037-06-07 Drug product 2023-12-26 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N217242-001 11793796 2037-06-07 Drug product 2023-12-26 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N217242-001 11819496 2037-06-07 U-4203 2023-12-26 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N217242-001 11819496 2037-06-07 U-3773 2023-12-26 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N217242-001 11992480 2037-06-07 U-4203 2024-06-26 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N217242-001 11992480 2037-06-07 U-3773 2024-06-26 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N217242-001 12005051 2037-06-07 U-4203 2024-07-10 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N217242-001 12005051 2037-06-07 U-3773 2024-07-10 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N217242-001 12005052 2037-06-07 Drug product 2024-07-10 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N217242-001 12011437 2037-06-07 Drug product 2024-07-10 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N217242-001 12016848 2037-06-07 Drug product 2024-07-10 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N217242-001 12042487 2037-06-07 Drug product 2024-08-16 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N217242-001 12220409 2037-06-07 Drug product 2025-03-07 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N217242-001 12257242 2037-06-07 Drug product 2025-04-22 011fe1cb6892…
Observed Orange Book exclusivity history# openFDA label cross-check# OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
Matched openFDA labels page 1 of 1 · 1 matching rows.
Brand, Generic, Manufacturer table Brand Generic Manufacturer SPL set ID Effective date Available safety fields Join ZORYVE ROFLUMILAST Arcutis Biotherapeutics, Inc. f9e0b4a9-a227-4947-b00c-41fb18d16589 2026-06-22 Warnings, Adverse reactions Exact identifier application applno (NDA): 217242 application number: NDA217242
Documents# Document, Submission type, Date table Document Submission type Date 82436 SUPPL 2025-06-03 82317 SUPPL 2025-05-27 79551 SUPPL 2024-09-06 79548 SUPPL 2024-09-06 78205 ORIG 2024-04-23 77064 ORIG 2023-12-19 76874 ORIG 2023-12-15